MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition
Author:
Funder
National Institutes of Health
Fellowship from the Jefferson-Pilot Corporation
Fondation Leducq
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Molecular Biology
Reference82 articles.
1. Executive summary: heart disease and stroke statistics–2012 update: a report from the American Heart Association;Roger;Circulation,2012
2. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications;Pfeffer;Circulation,1990
3. Controversies in ventricular remodelling;Opie;Lancet,2006
4. Novel pharmacotherapies to abrogate postinfarction ventricular remodeling;Dorn;Nat Rev Cardiol,2009
5. Inhibition of mitogen activated protein kinase activated protein kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo;Muto;Vascul Pharmacol,2012
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. AP39 inhibits ferroptosis by inhibiting mitochondrial autophagy through the PINK1/parkin pathway to improve myocardial fibrosis with myocardial infarction;Biomedicine & Pharmacotherapy;2023-09
2. Application of emetine in SARS-CoV-2 treatment: regulation of p38 MAPK signaling pathway for preventing emetine-induced cardiac complications;Cell Cycle;2022-07-19
3. The role of endothelin and RAS/ERK signaling in immunopathogenesis-related fibrosis in patients with systemic sclerosis: an updated review with therapeutic implications;Arthritis Research & Therapy;2022-05-13
4. The Potential Use of Cannabis in Tissue Fibrosis;Frontiers in Cell and Developmental Biology;2021-10-11
5. Mitogen‐activated protein kinase‐activated protein kinase‐2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer;Molecular Carcinogenesis;2021-09-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3